| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |